Cardio Diagnostics, Inc. (“Cardio Diagnostics” or the “Company”), a pioneering precision cardiovascular medicine company, and Mana Capital Acquisition Corp. (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR) (“Mana”), a special purpose acquisition company (“SPAC”), have announced that they have entered into a definitive business combination agreement that will result in Cardio Diagnostics becoming a publicly listed company. Read more on Business Wire.
